Agenda-setting intelligence, analysis and advice for the global fashion community.
Eli Lilly & Co. cautioned against using its popular diabetes and obesity drugs for “cosmetic weight loss” as off-label use of the medications has skyrocketed and shortages ensued.
Please sign in to ensure you can read our agenda-setting intelligence, analysis and advice. Or get in touch at support@businessoffashion.com if you experience difficulties.




